141 related articles for article (PubMed ID: 11073324)
21. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic characteristics of crevicular fluid aspartate aminotransferase (AST) levels associated with periodontal disease activity.
Persson GR; Page RC
J Clin Periodontol; 1992 Jan; 19(1):43-8. PubMed ID: 1732308
[TBL] [Abstract][Full Text] [Related]
23. Analysis of gingival crevicular fluid intracytoplasmic enzyme activity in patients with adult periodontitis and rapidly progressive periodontitis. A longitudinal study model with periodontal treatment.
Atici K; Yamalik N; Eratalay K; Etikan I
J Periodontol; 1998 Oct; 69(10):1155-63. PubMed ID: 9802716
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between levels of aspartate aminotransferase in gingival crevicular fluid and periodontal disease activity].
Yan F; Cao C; Li X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jan; 30(1):40-2, 64. PubMed ID: 7789235
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients.
Cox SW; Eley BM
J Clin Periodontol; 1992 May; 19(5):333-9. PubMed ID: 1355496
[TBL] [Abstract][Full Text] [Related]
26. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
27. Correlation of peri-implant health and aspartate aminotransferase levels: a cross-sectional clinical study.
Fiorellini JP; Nevins ML; Sekler J; Chung A; Oringer RJ
Int J Oral Maxillofac Implants; 2000; 15(4):500-4. PubMed ID: 10960982
[TBL] [Abstract][Full Text] [Related]
28. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H
J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190
[TBL] [Abstract][Full Text] [Related]
29. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.
Bhide VM; Smith L; Overall CM; Birek P; McCulloch CA
J Periodontol; 2000 May; 71(5):690-700. PubMed ID: 10872948
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal evaluation of aspartate aminotransferase in the crevicular fluid of implants with bone loss and signs of progressive disease.
Rühling A; Jepsen S; Kocher T; Plagmann HC
Int J Oral Maxillofac Implants; 1999; 14(3):428-35. PubMed ID: 10379118
[TBL] [Abstract][Full Text] [Related]
31. Correlation between gingivain/gingipain and bacterial dipeptidyl peptidase activity in gingival crevicular fluid and periodontal attachment loss in chronic periodontitis patients. A 2-year longitudinal study.
Eley BM; Cox SW
J Periodontol; 1996 Jul; 67(7):703-16. PubMed ID: 8832482
[TBL] [Abstract][Full Text] [Related]
32. Association of early onset periodontitis microbiota with aspartate aminotransferase activity in gingival crevicular fluid.
Kamma JJ; Nakou M; Persson RG
J Clin Periodontol; 2001 Dec; 28(12):1096-105. PubMed ID: 11737506
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R
J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892
[TBL] [Abstract][Full Text] [Related]
34. The relationship between gingival crevicular fluid cathepsin B activity and periodontal attachment loss in chronic periodontitis patients: a 2-year longitudinal study.
Eley BM; Cox SW
J Periodontal Res; 1996 Aug; 31(6):381-92. PubMed ID: 8884632
[TBL] [Abstract][Full Text] [Related]
35. A relationship between proteinase activity and clinical parameters in the treatment of periodontal disease.
Mailhot JM; Potempa J; Stein SH; Travis J; Sterrett JD; Hanes PJ; Russell CM
J Clin Periodontol; 1998 Jul; 25(7):578-84. PubMed ID: 9696259
[TBL] [Abstract][Full Text] [Related]
36. Microbiological features and crevicular fluid aspartate aminotransferase enzyme activity in early onset periodontitis patients.
Kuru B; Yilmaz S; Noyan U; Acar O; Kadir T
J Clin Periodontol; 1999 Jan; 26(1):19-25. PubMed ID: 9923506
[TBL] [Abstract][Full Text] [Related]
37. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
Konopka L; Pietrzak A; Brzezińska-Błaszczyk E
J Periodontal Res; 2012 Dec; 47(6):681-8. PubMed ID: 22510045
[TBL] [Abstract][Full Text] [Related]
38. Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: effects of phase I periodontal treatment.
Daltaban O; Saygun I; Bal B; Baloş K; Serdar M
J Periodontol; 2006 Jan; 77(1):67-72. PubMed ID: 16579705
[TBL] [Abstract][Full Text] [Related]
39. The relationship of beta-glucuronidase activity in crevicular fluid to clinical parameters of periodontal disease. Findings from a multicenter study.
Lamster IB; Holmes LG; Gross KB; Oshrain RL; Cohen DW; Rose LF; Peters LM; Pope MR
J Clin Periodontol; 1994 Feb; 21(2):118-27. PubMed ID: 8144731
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
